Celltrion identify 14 antibodies that neutralise COVID-19 virus
Celltrion Group has successfully selected the most potent antibody candidates to neutralise COVID-19 virus, SARS-CoV-2. Through a partnership with the Korea Centers for Disease Control...
UPDATED: MHRA guidance on coronavirus (COVID-19)
The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Advice on ibuprofen and coronavirus (COVID-19): Commission on Human Medicines
The Commission of Human Medicines (CHM) Expert Working Group on coronavirus (COVID-19) has given its advice on ibuprofen and coronavirus (COVID-19). It concluded that there is...
Interactive tool shows the science behind COVID-19 control measures
An online tool to illustrate the effects of different COVID-19 control measures has been developed by a team of University of Cambridge researchers. The ‘lowhighcovid’...
NICE COVID-19 guidelines for cystic fibrosis, COPD and dermatological conditions
NICE has published three more rapid guidelines on the care of patients with suspected and confirmed COVID-19, and in patients without COVID-19. They cover...
Industry responds to call to roll out coronavirus tests
The UK’s top pharmaceutical and diagnostic companies are teaming up to rapidly develop and roll out millions of coronavirus tests in the coming months...
Private hospital merger to be approved if local concerns addressed
The CMA has found that the completed private hospital merger between Circle and BMI does not raise UK-wide competition concerns but could reduce competition...
Cancer Research UK to cut funding by £44m
Cancer Research UK has announced that it has taken the difficult decision to cut funding to its existing grants and institutes by up to...
New vaccine platform used to develop COVID-19 vaccine candidates
UK biotech Imophoron has produced multiple COVID-19 vaccine candidates, based on its novel vaccine platform (ADDomer©), within weeks of the virus sequence being made...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Latest articles
Isle of Man set to become world-leading exporter of medicinal cannabis
The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...
The future of pharmaceutical manufacturing
When the World Health Organization (WHO) declared COVID-19 as a pandemic in March 2020, the pharmaceutical sector burst into action. By May, there were...
UK first for advanced therapy to treat rheumatoid arthritis
The National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) recommending the use of JYSELECA®▼ (filgotinib) on the...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
UK first for advanced therapy to treat rheumatoid arthritis
The National Institute for Health and Care Excellence (NICE) has issued a final appraisal determination (FAD) recommending the use of JYSELECA®▼ (filgotinib) on the...
JCVI updates priority list for COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...